Literature DB >> 9772277

Multifunctional potential of the plasminogen activation system in tumor invasion and metastasis (review).

U Reuning1, V Magdolen, O Wilhelm, K Fischer, V Lutz, H Graeff, M Schmitt.   

Abstract

Tumor cell migration and invasion into the surrounding tissue depend on the invasive capacity of cells leading to the loosening of cell-cell and cell-substratum contacts via cell surface associated proteolytic enzyme systems. Plasmin is one of the enzymes involved in these complex events. It is generated by the cleavage of the proenzyme plasminogen upon the action of the urokinase-type plasminogen activator (uPA). uPA is synthesized and secreted by tumor cells and normal cells and interacts with a specific cell surface receptor (uPAR) thereby focalizing enzymatic activity to the cell surface. The activity of uPA is controlled by plasminogen activator inhibitors type-1 and type-2. A strong statistically independent prognostic impact has been attributed to uPA and its inhibitor PAI-1 in a variety of malignancies. Besides its proteolytic activity, uPA in concert with uPAR exert biological effects characteristic for molecules with signal transducing properties including chemotaxis, migration/invasion, adhesion, and mitogenesis.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9772277     DOI: 10.3892/ijo.13.5.893

Source DB:  PubMed          Journal:  Int J Oncol        ISSN: 1019-6439            Impact factor:   5.650


  37 in total

1.  Immunohistochemical expression of uPA, uPAR, and PAI-1 in breast carcinoma. Fibroblastic expression has strong associations with tumor pathology.

Authors:  E Dublin; A Hanby; N K Patel; R Liebman; D Barnes
Journal:  Am J Pathol       Date:  2000-10       Impact factor: 4.307

2.  The Oral Serine Protease Inhibitor WX-671 - First Experience in Patients with Advanced Head and Neck Carcinoma.

Authors:  Jens E Meyer; Carsten Brocks; Hendrik Graefe; Carola Mala; Natalie Thäns; Markus Bürgle; Annette Rempel; Nicole Rotter; Barbara Wollenberg; Stephan Lang
Journal:  Breast Care (Basel)       Date:  2008-10-16       Impact factor: 2.860

3.  The p75(NTR) metastasis suppressor inhibits urokinase plasminogen activator, matrix metalloproteinase-2 and matrix metalloproteinase-9 in PC-3 prostate cancer cells.

Authors:  Angèle Nalbandian; Daniel Djakiew
Journal:  Clin Exp Metastasis       Date:  2006-08-16       Impact factor: 5.150

4.  (4-aminomethyl)phenylguanidine derivatives as nonpeptidic highly selective inhibitors of human urokinase.

Authors:  S Sperl; U Jacob; N Arroyo de Prada; J Stürzebecher; O G Wilhelm; W Bode; V Magdolen; R Huber; L Moroder
Journal:  Proc Natl Acad Sci U S A       Date:  2000-05-09       Impact factor: 11.205

5.  Downregulation of uPAR confirms link in growth and metastasis of osteosarcoma.

Authors:  Crispin R Dass; Anne P W Nadesapillai; Daniel Robin; Monique L Howard; Jane L Fisher; Hong Zhou; Peter F M Choong
Journal:  Clin Exp Metastasis       Date:  2006-04-29       Impact factor: 5.150

6.  Transcriptional regulation of urokinase-type plasminogen activator receptor by hypoxia-inducible factor 1 is crucial for invasion of pancreatic and liver cancer.

Authors:  Peter Büchler; Howard A Reber; James S Tomlinson; Oliver Hankinson; Georgis Kallifatidis; Helmut Friess; Ingrid Herr; Oscar J Hines
Journal:  Neoplasia       Date:  2009-02       Impact factor: 5.715

7.  Berberine inhibits the migration and invasion of T24 bladder cancer cells via reducing the expression of heparanase.

Authors:  Lei Yan; Keqiang Yan; Wang Kun; Lin Xu; Qian Ma; Yueqing Tang; Wei Jiao; Gangli Gu; Yidon Fan; Zhonghua Xu
Journal:  Tumour Biol       Date:  2012-10-12

8.  Modulation of glioma cell invasion and motility by adenoviral gene transfer of PAI-1.

Authors:  G O Hjortland; K Bjørnland; S Pettersen; S S Garman-Vik; E Emilsen; J M Nesland; O Fodstad; O Engebraaten
Journal:  Clin Exp Metastasis       Date:  2003       Impact factor: 5.150

9.  The urokinase plasminogen activator receptor promotes efferocytosis of apoptotic cells.

Authors:  Veera D'mello; Sukhwinder Singh; Yi Wu; Raymond B Birge
Journal:  J Biol Chem       Date:  2009-04-21       Impact factor: 5.157

10.  Binding of tissue-type plasminogen activator to the glucose-regulated protein 78 (GRP78) modulates plasminogen activation and promotes human neuroblastoma cell proliferation in vitro.

Authors:  Mario Gonzalez-Gronow; Cristian Farias Gomez; Gustaaf G de Ridder; Rupa Ray; Salvatore V Pizzo
Journal:  J Biol Chem       Date:  2014-07-24       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.